Loading viewer...
investor_presentation
Format: PDF investor_presentation
Novo Nordisk's full year 2023 investor presentation outlining progress on strategic aspirations, financial results, innovation initiatives, and commercial execution. The healthcare company focuses on therapeutic areas including obesity treatment and diabetes management with products such as Wegovy, Ozempic, and Saxenda.
investor_presentation
13 Pages
Novo Nordisk Full Year 2020 Investor Presentation
investor_presentationinvestor_presentation
130 Pages
investor_presentation
6 Pages
Dave & Buster’s Entertainment
Karyopharm Therapeutics Investor Presentation — June 2020
investor_presentationinvestor_presentation
57 Pages
Karyopharm Therapeutics Inc.